Influence of minimum inhibitory concentration in clinical outcomes of enterococcus faecium bacteremia treated with daptomycin: is it time to change the breakpoint?

Simple item page
dc.contributor.authorShukla, Bhavarth
dc.contributor.authorShelburne, Samuel
dc.contributor.authorReyes, Katherine
dc.contributor.authorKamboj, Mini
dc.contributor.authorLewis, Jessica
dc.contributor.authorRincon, Sandra
dc.contributor.authorReyes, Jinnethe
dc.contributor.authorCarvajal, Lina
dc.contributor.authorPanesso, Diana
dc.contributor.authorSifri, Costi
dc.contributor.authorZervos, Marcus
dc.contributor.authorPamer, Eric
dc.contributor.authorTran, Truc
dc.contributor.authorAdachi, Javier
dc.contributor.authorMunita, José
dc.contributor.authorHasbun, Rodrigo
dc.contributor.authorArias, Cesar
dc.date.accessioned2017-05-15T14:23:05Z
dc.date.available2017-05-15T14:23:05Z
dc.date.issued2016
dc.description.abstractBACKGROUND: Daptomycin has become a front-line antibiotic for multidrug-resistant Enterococcus faecium bloodstream infections (BSIs). We previously showed that E. faecium strains with daptomycin minimum inhibitory concentrations (MICs) in the higher end of susceptibility frequently harbor mutations associated with daptomycin resistance. We postulate that patients with E. faecium BSIs exhibiting daptomycin MICs of 3-4 µg/mL treated with daptomycin are more likely to have worse clinical outcomes than those exhibiting daptomycin MICs ≤2 µg/mL. METHODS: We conducted a multicenter retrospective cohort study that included adult patients with E. faecium BSI for whom initial isolates, follow-up blood culture data, and daptomycin administration data were available. A central laboratory performed standardized daptomycin MIC testing for all isolates. The primary outcome was microbiologic failure, defined as clearance of bacteremia ≥4 days after the index blood culture. The secondary outcome was all-cause in-hospital mortality. RESULTS: A total of 62 patients were included. Thirty-one patients were infected with isolates that exhibited daptomycin MICs of 3-4 µg/mL. Overall, 34 patients had microbiologic failure and 25 died during hospitalization. In a multivariate logistic regression model, daptomycin MICs of 3-4 µg/mL (odds ratio [OR], 4.7 [1.37-16.12]; P = .014) and immunosuppression (OR, 5.32 [1.20-23.54]; P = .028) were significantly associated with microbiologic failure. Initial daptomycin dose of ≥8 mg/kg was not significantly associated with evaluated outcomes. CONCLUSIONS: Daptomycin MICs of 3-4 µg/mL in the initial E. faecium blood isolate predicted microbiological failure of daptomycin therapy, suggesting that modification in the daptomycin breakpoint for enterococci should be considered.
dc.format.extent7
dc.identifier.citationShukla BS, Shelburne S, Reyes K, Kamboj M, Lewis JD, Rincon SL, Reyes J, Carvajal LP, Panesso D, Sifri CD, Zervos MJ, Pamer EG, Tran TT, Adachi J, Munita JM, Hasbun R, Arias CA. Influence of Minimum Inhibitory Concentration in Clinical Outcomes of Enterococcus faecium Bacteremia Treated With Daptomycin: Is it Time to Change the Breakpoint? Clin Infect Dis. 2016 Jun 15;62(12):1514-1520.
dc.identifier.urihttp://hdl.handle.net/11447/1243
dc.identifier.urihttp://dx.doi.org/10.1093/cid/ciw173
dc.language.isoen_US
dc.publisherOxford University Press
dc.subjectE. faecium
dc.subjectMIC
dc.subjectbloodstream infection
dc.subjectdaptomycin
dc.subjectresistance
dc.titleInfluence of minimum inhibitory concentration in clinical outcomes of enterococcus faecium bacteremia treated with daptomycin: is it time to change the breakpoint?
dc.typeArtículo

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Influence of Minimum Inhibitory Concentration in Clinical Outcomes of Enterococcus faecium Bacteremia Treated with Daptomycin Is it Time to Change the Breakpoint
Size:
236.29 KB
Format:
Unknown data format
Description:
Texto completo
Download

Collections

Artículos Medicina y Ciencias de la Salud

Implementado por OpenGeek Services